Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

OMNIPEN (AMPICILLIN)

AMPICILLIN/AMPICILLIN TRIHYDRATE

Standard Dose
250MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060625 (ANDA).

Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - 250MG/5ML Sponsor WYETH AYERST Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060625 (ANDA). Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - 250MG/5ML Sponsor WYETH AYERST Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
OMNIPEN (AMPICILLIN) (AMPICILLIN/AMPICILLIN TRIHYDRATE) | Drug Monograph | MedicHelpline